Quick Answer
REGENEREX PHARMA, INC. reported Total Assets of $1.26 million for fiscal year 2025.
REGENEREX PHARMA, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.26M | +64.8% |
| 2024 | $766.7K | +11624.7% |
| 2023 | $6.5K | -57.3% |
| 2022 | $15.3K | +46.3% |
| 2021 | $10.5K | -96.0% |
| 2020 | $259.2K | +145.4% |
| 2019 | $105.6K | +600.9% |
| 2018 | $15.1K | +294.6% |
| 2014 | $3.8K | -92.5% |
| 2013 | $51.0K | +352.3% |
| 2012 | $11.3K | -85.3% |
| 2011 | $76.8K | +1120.7% |
| 2010 | $6.3K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $617.8K | -2.4% | -19.1% |
| June 30, 2025 | $763.4K | +4.7% | -39.6% |
| March 31, 2025 | $1.26M | +64.8% | +95.3% |
| December 31, 2024 | $646.9K | -24.1% | +2.2% |
| September 30, 2024 | $633.0K | -32.1% | -13.2% |
| June 30, 2024 | $729.1K | -29.9% | -4.9% |
| March 31, 2024 | $766.7K | +11624.7% | -10.0% |
| December 31, 2023 | $852.1K | +8482.4% | -8.6% |
- REGENEREX PHARMA, INC. showed an increase of +64.8% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, REGENEREX PHARMA, INC.’s total assets has grown by 19983.2% (from $6.3 thousand to $1.26 million).
- The most recent figure is from REGENEREX PHARMA, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: